Kiora Pharmaceuticals

Kiora Pharmaceuticals (formerly known as Panoptes Pharma) is a clinical-stage biotech company focused on developing small molecule-based therapies for the treatment of severe eye diseases. Its development program is devoted to the treatment of orphan autoimmune uveitis. In addition, the company focuses on viral conjunctivitis, dry eye disease, diabetic retinopathy, and other medical conditions.